Being part of clinical trials can be a profitable way to help advance research, but there are many trade-offs to consider.
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set ...
Some screenings and treatments no longer make sense for patients as they age. Researchers have just added a few more to the ...
The rescheduling of medical cannabis marks one of the most significant U.S. drug policy shifts in years, potentially easing ...
Evidence shows that research designed with communities — through shared governance, fair compensation, and mutual ...
Researchers have just completed one of the largest-yet studies comparing artificial intelligence and physicians across a wide ...
Rochester is a hub for small organizations focused on helping patients or funding medical research grants. Often, these ...
Unfortunately, the resources don't exist to take every flat-earther to the International Space Station to change their mind,” ...
Animal rescuers in Wisconsin have reached a deal to purchase over a thousand beagles from a veterinary research facility.
It is quite possible that in the near future, people will have to describe their symptoms to an AI before they can get a ...
Highlighting the oral-gut microbiome in cancer development, research from China suggests a strong association between mouth ...
The federal government no considers medical marijuana to be as addictive or dangerous as heroin or cocaine, following a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results